Breakdown | |||||
TTM | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
21.96M | 13.66M | 9.58M | 7.63M | 5.67M | 6.12M | Gross Profit |
7.43M | 3.97M | 1.55M | 487.88K | 67.55K | 738.55K | EBIT |
5.97M | 1.01M | -2.48M | -3.06M | -985.57K | -308.40K | EBITDA |
8.59M | 2.60M | -1.53M | -2.23M | -3.46K | -52.65K | Net Income Common Stockholders |
6.68M | 1.16M | -2.59M | -3.38M | -840.36K | -705.65K |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
3.41M | 2.29M | 1.64M | 1.98M | 2.54M | 217.80K | Total Assets |
20.40M | 23.89M | 20.98M | 17.92M | 14.67M | 10.85M | Total Debt |
1.95M | 2.32M | 2.25M | 3.86M | 2.40M | 1.42M | Net Debt |
-1.46M | 29.65K | 611.61K | 1.89M | -138.87K | 1.20M | Total Liabilities |
3.06M | 3.35M | 3.27M | 4.86M | 3.40M | 2.20M | Stockholders Equity |
14.47M | 17.75M | 14.88M | 10.17M | 8.31M | 5.65M |
Cash Flow | Free Cash Flow | ||||
4.17M | -71.34K | -3.96M | -4.44M | -2.08M | 86.19K | Operating Cash Flow |
8.87M | 2.10M | -1.82M | -1.35M | -482.42K | 206.41K | Investing Cash Flow |
-10.79M | -2.10M | -2.37M | -3.09M | -1.59M | 79.78K | Financing Cash Flow |
8.35M | 647.19K | 3.85M | 3.88M | 4.40M | -317.16K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
70 Outperform | $3.11B | 33.77 | 5.49% | ― | 27.30% | ― | |
55 Neutral | $204.43M | 22.30 | 31.88% | ― | 88.66% | 619.17% | |
51 Neutral | $361.90M | 3.61 | -8.76% | ― | 4.96% | -182.95% | |
47 Neutral | $2.36B | -2.99 | -21.59% | 3.58% | 4.21% | -28.30% | |
46 Neutral | $41.21M | ― | -57.78% | ― | -33.14% | -170.75% |
On January 15, 2025, Idaho Strategic Resources, Inc. approved a one-time stock option grant to its employees, executive officers, and directors as part of its 2023 Equity Incentive Compensation Plan. This grant, aimed at aligning individual interests with stockholder interests and retaining key personnel, included a total of 425,000 options priced at a 10% premium to the market price, with specific allocations to directors and officers, and the remainder distributed among other employees.